Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Tyrosine in TNNT1-Myopathy
NCT02035501Phase 2Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Jan 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tyrosine in Nemaline myopathy (NM), sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
tyrosine
03
Conditions
Nemaline myopathy (NM)
Beyond the preview
Go deeper on NCT02035501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02035501.